P282 Survival outcomes after neoadjuvant chemotherapy according to the axillary status and tumor subtype

MLA

L. López-Marín, et al. “P282 Survival Outcomes after Neoadjuvant Chemotherapy According to the Axillary Status and Tumor Subtype.” Breast, vol. 68, no. S128-, Mar. 2023. EBSCOhost, https://doi.org/10.1016/S0960-9776(23)00400-9.

APA

L. López-Marín, M. Ciáurriz, E.V. Powell, M.L. Arroyo, M. Blanco, M.C. Sanz, M. Gallego, S. Aragón, & M. Ciaurriz. (2023). P282 Survival outcomes after neoadjuvant chemotherapy according to the axillary status and tumor subtype. Breast, 68(S128-). https://doi.org/10.1016/S0960-9776(23)00400-9

Chicago

L. López-Marín, M. Ciáurriz, E.V. Powell, M.L. Arroyo, M. Blanco, M.C. Sanz, M. Gallego, S. Aragón, and M. Ciaurriz. 2023. “P282 Survival Outcomes after Neoadjuvant Chemotherapy According to the Axillary Status and Tumor Subtype.” Breast 68 (S128-). doi:10.1016/S0960-9776(23)00400-9.